Phenyloxadiazole derivatives as PGDS inhibitors
US9469627B2 · kind B2 · utility
1Cited by
4References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 4, 2012 |
| Grant date | Oct 18, 2016 |
| Priority date | — |
| Expiry date | Apr 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to a compound of formula (I):wherein R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising the compound, intermediates and processes for making said compounds, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma, chronic obstructive pulmonary disease (COPD) and age-related macular degeneration (AMD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.